Telix Pharmaceuticals Limited (ASX:TLX)

Australia · Delayed Price · Currency is AUD

16.09

+0.51 (3.27%)

Aug 28, 2026, 10:24 AM AEST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Jan '24 Jan 1, 2024	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Manufacturing Solutions	245.11M	1.82M	277.00K	-		-
Precision Medicine	621.93M	508.51M	329.21M	-		-
Inter-Segment Elimination	-72.51M	-	-	-		-
Therapeutics	9.27M	6.23M	3.50M	-		-
Commercial	-	-	-	106.28M		-
Product Development	-	-	-	2.53M		-
Pharmaceuticals	-	-	-	-		4.02M
Total	803.79M	516.55M	332.98M	108.81M		4.02M

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Jan '24 Jan 1, 2024	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States	784.91M	502.76M	324.47M	101.95M		-
Other Countries	9.06M	13.41M	7.64M	2.70M		-
Australia	-	-	-	101.27K		4.02M
Belgium	-	-	-	383.33K		-
United Kingdom	-	-	-	1.39M		-
China	9.83M	382.00K	863.00K	2.28M		-
Total	803.79M	516.55M	332.98M	108.81M		4.02M